• March 2022
  Preclinical data of BM219, an inhalable bispecific UDAB with broad neutralization of SARS-CoV-2 variants, was published in Cell
  Read More
• December 2021
  Interview with Dr. Chao Tu, a forward-thinker in discovering and development of fully-human domain antibody (UDAB)
  Read More
• November 2021
  Official opening ceremony of Shanghai R&D center
  Read More
• February 2021
  Prof. Shibo Jiang elected Fellow of American Academy of Microbiology (AAM)
  Read More
• September 2020
  Closed Series A Fund-raising of USD $25M led by Fosun Health Capital
  Read More